TRAUMA
AAOS2018: Routine chemoprophylaxis for VTE unnecessary in fractures of tibia and distally
Five randomized controlled trials were included in this meta-analysis comparing the rates of venous thromboembolism and clinically-relevant venous thromboembolism after operative management of fractures in the tibia and distally between chemoprophylaxis groups and control groups. While a significant reduction in the incidence of venous thromboembolism overall was observed with chemoprophylaxis, no significant difference between groups was observed in the incidence of clinically-important venous thromboembolism.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
